SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15111537
Source:
http://linkedlifedata.com/resource/pubmed/id/15111537
Search
Subject
(
52
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0031117
,
umls-concept:C0149322
,
umls-concept:C0205296
,
umls-concept:C0449258
,
umls-concept:C2348561
pubmed:issue
5
pubmed:dateCreated
2004-4-27
pubmed:abstractText
The aim of this study was to report the baseline and natural progression of diabetic peripheral neuropathy over 12 months in a large mild-to-moderate neuropathy population.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7805975
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Aldehyde Reductase
,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0149-5992
pubmed:author
pubmed-author:BirdShawn JSJ
,
pubmed-author:BrownMark JMJ
,
pubmed-author:EckertStephenS
,
pubmed-author:FoytHoward LHL
,
pubmed-author:GiangregorioL MLM
,
pubmed-author:HayesLeeL
,
pubmed-author:WatlingSharonS
,
pubmed-author:Zenarest study
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1153-9
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:15111537-Aldehyde Reductase
,
pubmed-meshheading:15111537-Diabetes Mellitus, Type 1
,
pubmed-meshheading:15111537-Diabetes Mellitus, Type 2
,
pubmed-meshheading:15111537-Diabetic Neuropathies
,
pubmed-meshheading:15111537-Disease Progression
,
pubmed-meshheading:15111537-Enzyme Inhibitors
,
pubmed-meshheading:15111537-Female
,
pubmed-meshheading:15111537-Humans
,
pubmed-meshheading:15111537-Male
,
pubmed-meshheading:15111537-Median Nerve
,
pubmed-meshheading:15111537-Middle Aged
,
pubmed-meshheading:15111537-Motor Neurons
,
pubmed-meshheading:15111537-Neural Conduction
,
pubmed-meshheading:15111537-Neurons, Afferent
,
pubmed-meshheading:15111537-Sensation
,
pubmed-meshheading:15111537-Sural Nerve
,
pubmed-meshheading:15111537-Time Factors
pubmed:year
2004
pubmed:articleTitle
Natural progression of diabetic peripheral neuropathy in the Zenarestat study population.
pubmed:affiliation
Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
pubmed:publicationType
Journal Article